Overview

Takayasu Arteritis Clinical Trial in China

Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and Safety of Leflunomide in Patients With Active Phase of Takayasu's Arteritis
Phase:
N/A
Details
Lead Sponsor:
Jiang lindi
Treatments:
Leflunomide
Prednisone